International research focuses on regenerative medicine
July 12, 2012
Topic: minimally invasive orthopaedic surgery
Scientists from all around the world are working hard to bring regenerative medicine that uses stem cell techniques to the clinic. This approach may enhance minimally invasive orthopaedic surgery procedures that treat problems in patients' muscles and bones.
In Europe, 21 research teams across the continent are participating in the Biodesign project, which is developing injectable agents that will stimulate stem cells in the body to repair tissue damage.
"Current biomaterials are poorly suited to the needs of tissue engineering and regenerative medicine. The aim of Biodesign is to develop new materials and medicines that will stimulate tissue regeneration rather than wait for the body to start the process itself," said Kevin Shakesheff, a scientist from the University of Nottingham.
Many repair processes in the body are similar in that they require the regrowth of tissue. Biodesign scientists hope to create injectable medicine that provides a foundation upon which tissue repair can take place. If successful, this approach may help treat conditions such as osteoporosis and muscle injury.
Researchers at the Andrews Institute have also taken a great interest in stem cell medicine. Here, scientists are working with the U.S. Food and Drug Administration in order to find a suitable class of adult stem cells that may help treat orthopaedic injuries.
- Corn soluble fiber increases calcium absorption – 7/18/2014
- Subcutaneous tocilizumab: New treatment option for rheumatoid arthritis patients – 7/16/2014
- Doctors can detect risk of cardiovascular disease for RA patients – 7/7/2014
- Hips are best way to detect extreme sports injury – 7/7/2014
- New study proves ability for bone development – 6/30/2014